A 38-year-old woman has FSH 42 IU/L, AMH 0.1 ng/mL, and irregular periods for 6 months. She is diagnosed with premature ovarian insufficiency (POI). Which is the MOST IMPORTANT treatment consideration?
- A Hormone replacement therapy (HRT) until the age of natural menopause (approximately 51 years) to protect bone, cardiovascular health, and cognitive function ✓
- B Ovulation induction with clomiphene citrate for fertility
- C GnRH agonist to suppress residual ovarian activity
- D Observation as spontaneous recovery occurs in 50% of cases
Correct answer: A. Hormone replacement therapy (HRT) until the age of natural menopause (approximately 51 years) to protect bone, cardiovascular health, and cognitive function
Explanation
Premature ovarian insufficiency (POI, occurring before age 40) is associated with increased risks of osteoporosis, cardiovascular disease, and neurocognitive decline due to prolonged estrogen deficiency. HRT (estrogen with progestogen in women with uterus) is the cornerstone of management and should be continued until the average age of natural menopause (~51 years). Unlike in post-menopausal women, HRT in POI is replacement — not excess — and does not carry the same breast cancer risk as post-menopausal HRT.
Reference: Shaw's Textbook of Gynaecology, 17th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.